Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: Results of a randomized, multicenter, phase III trial

1. Nabholtz, J.-M.
2. Falkson, C.
3. Campos, D.
4. Szanto, J.
5. Martin, M.
6. Chan, S.
7. Pienkowski, T.
8. Zaluski, J.
9. Pinter, T.
10. Krzakowski, M.
11. Vorobiof, D.
12. Leonard, R.
13. Kennedy, I.
14. Azli, N.
15. Murawsky, M.
16. Riva, A.
17. Pouillart, P.